American Society of Clinical Oncology

SHERPA: White

People

  1. Aghajanian
    Aghajanian
  2. De Stanchina
    De Stanchina
  3. Grisham
    Grisham
  4. Iasonos
    Iasonos
  5. Ilson
    Ilson
  6. Iyer
    Iyer
  7. Kelsen
    Kelsen
  8. O'Reilly
    O'Reilly
  9. Rosales
    Rosales
  10. Saltz
    Saltz

Groups

  1. Adult Leukemia (6)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (5)
  4. Hematologic Malignancies, Division of (4)
  5. GSK Faculty (3)
  6. Hematologic Malignancies Research (3)
  7. Solid Tumor Oncology Division (2)
  8. Biostatistics Service (1)
  9. Center for Pancreatic Cancer Research (1)
  10. Epidemiology and Biostatistics (1)
Search Within
  1. "Adult Leukemia"
  2. "David Spriggs"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
Groups
  1. Adult Leukemia (6)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (5)
  4. Hematologic Malignancies, Division of (4)
  5. GSK Faculty (3)
  6. Hematologic Malignancies Research (3)

More Groups

People
  1. David Spriggs (6)
  2. Renier Brentjens (3)
  3. Dharmarao Thapi (2)
  4. Oladapo Yeku (2)
  5. Terence Purdon (2)
  6. Alena Chekmasova (1)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2014 (1)
  4. 2012 (1)
  5. 2007 (1)
  6. 2002 (1)
Publications
  1. Journal of Clinical Oncology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interleukin-12 armored chimeric antigen receptor (CAR) T cells for heterogeneous antigen-expressing ovarian cancer
    Meeting Abstract

    Yeku, O. O.; Purdon, T.; Spriggs, D. R.; Brentjens, R. J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T cells genetically engineered to deliver IL-12 to the tumor microenvironment in ovarian cancer
    Meeting Abstract

    Yeku, O. O.; Purdon, T.; Spriggs, D. R.; Brentjens, R. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Effect of enzalutamide (Enza) on androgen receptor (AR) positive (+) ovarian cancer
    Meeting Abstract

    Grisham, R. N.; Thapi, D.; Berman, T.; de Stanchina, E.; Zhou, Q.; Iasonos, A.; Iyer, G.; Aghajanian, C.; Spriggs, D. R.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Effect of modulation of the hostile tumor microenvironment through adoptive transfer of IL-12 expressing MUC-16 targeted T cells on ovarian tumors in vivo
    Meeting Abstract

    Chekmasova, A. A.; Sandadi, S.; Spriggs, D. R.; Brentjens, R. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • The MUC16 mucin gene upregulates gene transcripts associated with invasion
    Meeting Abstract

    Diaz, J. P.; Kehoe, S.; Thapi, D.; Rosales, N.; Ma, X.; Yan, X. J.; Spriggs, D. R.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors
    Journal Article

    Schwartz, G. K.; O'reilly, E.; Ilson, D.; Saltz, L.; Sharma, S.; Tong, W.; Maslak, P.; Stoltz, M.; Eden, L.; Perkins, P.; more...
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save